Skip to content
Politics
Prognosis

Sinovac’s Covid-19 Shot Approved for Use in South Africa

Vials of Sinovac Biotech Ltd.'s CoronaVac SARS-CoV-2 vaccine.

Vials of Sinovac Biotech Ltd.'s CoronaVac SARS-CoV-2 vaccine.

Photographer: Nicolas Bock/Bloomberg

Sinovac Biotech Ltd.’s Coronavac Covid-19 vaccine has been registered for use in South Africa, the national health products regulator said. 

The vaccine has a shelf-life of two years when stored between 2 and 8 degrees celsius, the South African Health Products Regulatory Authority said in a statement on Friday.